Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alcohol interaction study of GSK1144814 in healthy volunteers
NL-OMON32631Active, not recruiting
- Sponsor
- GSK
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of elinzanetant in alcohol dependence, schizophrenia, major depressive disorder (MDD) and 1 more (2 arms), sponsored by GSK. Primary endpoints: Saccadic eye movements, Smooth pursuit eye movements and 6 more. Started Nov 2009; status: active, not recruiting.
02
Drugs
elinzanetant
03
Conditions
alcohol dependenceschizophreniamajor depressive disorder (MDD)substance use disorder (SUD)
Beyond the preview
Go deeper on NL-OMON32631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32631.